Clinical trials
Leukemia trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 10 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 5 |
| Princess Maxima Center for Pediatric Oncology | 4 |
| Novartis Pharmaceuticals | 3 |
| Bristol-Myers Squibb | 2 |
| Mats Heyman | 2 |
| Aarhus University Hospital | 1 |
| Acerta Pharma BV | 1 |
| Ariad Pharmaceuticals | 1 |
| Celgene | 1 |
| Celgene Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 35 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Leukemia, Myeloid, Acute | 7 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 6 |
| Bone Marrow Diseases | 4 |
| Leukemia, Myeloid | 4 |
| Neoplasms | 4 |
| Bronchiolitis Obliterans Syndrome | 3 |
| Hematologic Diseases | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.